Charles River Laboratories Intl (CRL)
114.00 x 1 135.92 x 1
Post-market by (Cboe BZX)
114.66 -1.10 (-0.95%) 04/25/25 [NYSE]
114.00 x 1 135.92 x 1
Post-market 114.66 unch (unch) 16:43 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 25,291 | 480,370 | 492,608 | 398,837 | 365,306 |
Depreciation Amortization | 576,741 | 314,124 | 303,870 | 265,540 | 234,924 |
Income taxes - deferred | -67,428 | -50,903 | -35,884 | -24,006 | -133 |
Accounts receivable | 21,612 | -33,434 | -150,570 | -26,633 | -85,627 |
Accounts payable and accrued liabilities | -14,271 | -20,427 | -2,652 | 44,901 | 748 |
Other Working Capital | -30,329 | -102,380 | -152,554 | 42,942 | -26,275 |
Other Operating Activity | 222,961 | 96,548 | 164,822 | 59,218 | 57,632 |
Operating Cash Flow | $734,577 | $683,898 | $619,640 | $760,799 | $546,575 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -52,876 | -54,215 | -158,274 | -45,555 | -26,692 |
PPE Investments | -232,967 | -318,528 | -324,733 | -228,772 | -166,560 |
Net Acquisitions | -5,479 | -194,785 | -120,117 | -1,170,401 | -418,628 |
Sale Of Investment | 41,687 | 6,667 | 4,549 | 6,532 | 11,401 |
Other Investing Activity | 4,549 | -2,294 | -9,347 | 264 | -1,065 |
Investing Cash Flow | $-245,086 | $-563,155 | $-607,922 | $-1,437,932 | $-601,544 |
Cash Flows From Financing Activities | |||||
Debt Issued | 1,081,581 | 776,353 | 2,952,430 | 6,951,113 | 2,230,988 |
Debt Repayment | -1,493,769 | -851,676 | -2,932,636 | -6,281,132 | -2,200,400 |
Common Stock Issued | 23,878 | 25,597 | 25,110 | 45,652 | 46,586 |
Common Stock Repurchased | -119,175 | -24,155 | -38,651 | -40,707 | -23,979 |
Other Financing Activity | -43,442 | -11,640 | -48,650 | -2,328 | -5,947 |
Financing Cash Flow | $-550,927 | $-85,521 | $-42,397 | $672,598 | $47,248 |
Exchange Rate Effect | -17,474 | 8,044 | 25,579 | 17,730 | 794 |
Beginning Cash Position | 284,480 | 241,214 | 246,314 | 233,119 | 240,046 |
End Cash Position | 205,570 | 284,480 | 241,214 | 246,314 | 233,119 |
Net Cash Flow | $-78,910 | $43,266 | $-5,100 | $13,195 | $-6,927 |
Free Cash Flow | |||||
Operating Cash Flow | 734,577 | 683,898 | 619,640 | 760,799 | 546,575 |
Capital Expenditure | -232,967 | -318,528 | -324,733 | -228,772 | -166,560 |
Free Cash Flow | 501,610 | 365,370 | 294,907 | 532,027 | 380,015 |